The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...

An ongoing trial at the Medical University of South Carolina is looking for a breakthrough for patients dealing with heart ...

Having battled postpartum depression twice, biotech entrepreneur and neuroscientist Dr Clarissa Yates is developing a blood ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...

Edmonton, AB – December 22, 2025 – PRESSADVANTAGE – A first in western Canada, access to TIER-1 ENDOSURE testing for the ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million ...

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...

A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the ...

Since Froedtert Hospital adopted the test, the mortality rate for sepsis patients has decreased by 42% and hospital length of ...

The FDA-approved trial in Arizona explores whole-mushroom psilocybin therapy for PTSD with first responders and veterans.

Women with risk-based screening had about 30 cases of advanced cancer per 100,000 person-years, compared with 48 cases per ...